Comments
Bristol-Myers drops hepatitis C drug after patient death
24.08.2012. | (Reuters) - Bristol-Myers Squibb Co has discontinued development of an experimental hepatitis C drug after a patient treated with it during a clinical trial died of heart failure and several others were hospitalized, the company said on Thursday....
